Quoin Pharmaceuticals (QNRX) Selling, General & Administrative (2021 - 2026)
Quoin Pharmaceuticals (QNRX) recorded Selling, General & Administrative of $1.85 million in the quarter ended Jun 30, 2026, up 6.0% from $1.74 million a year earlier and up 8.8% from the prior quarter.
Quoin Pharmaceuticals (QNRX) Selling, General & Administrative (2021 - 2026) Analysis & Trends
On a TTM basis, Quoin Pharmaceuticals' Selling, General & Administrative came in at $6.71 million as of Jun 30, 2026, up 9.4% year-over-year; for the year ended Dec 31, 2025, it was $6.49 million, up 9.5% from the prior year.
- Annual Selling, General & Administrative has a five-year compound annual growth rate of 35.4% (years ended Dec 2020 to Dec 2025).
- Across earlier years, Selling, General & Administrative came in at $5.93 million in the year ended Dec 31, 2024 (-2.4%), $6.07 million in the year ended Dec 31, 2023 (-7.8%), $6.58 million in the year ended Dec 31, 2022 (+46.3%) and $4.5 million in the year ended Dec 31, 2021 (+215.6%).
- The figure for the quarter ended Jun 30, 2026 is the highest quarterly Selling, General & Administrative since the quarter ended Jun 30, 2022.
- On a year-over-year basis, Selling, General & Administrative has increased for six consecutive quarters, with growth averaging 6.9% over the last eight quarters.
- Peak year-over-year performance for Selling, General & Administrative in the last five years was growth of 163.2% in the quarter ended Jun 30, 2022, against a decline of 25.4% in the quarter ended Dec 31, 2022 at the low end.
- Per Business Quant, the preceding three quarters came in at $1.7 million (quarter ended Mar 31, 2026), $1.42 million (quarter ended Dec 31, 2025) and $1.74 million (quarter ended Sep 30, 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | SG&A (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,137.66 Bn | 1,106.24 Bn | 19.71 Bn | 3.43 Bn |
| 2 | Johnson & Johnson | 636.13 Bn | 556.00 Bn | 17.30 Bn | 6.29 Bn |
| 3 | AbbVie | 505.28 Bn | 478.39 Bn | 12.70 Bn | 3.63 Bn |
| 4 | Merck | 358.10 Bn | 312.48 Bn | 12.21 Bn | 2.90 Bn |
| 5 | Novartis Ag | 292.59 Bn | 256.58 Bn | 11.24 Bn | 3.24 Bn |
| 6 | Astrazeneca | 265.81 Bn | 239.50 Bn | 12.86 Bn | 5.65 Bn |
| 7 | Amgen | 237.53 Bn | 192.93 Bn | 7.24 Bn | 1.75 Bn |
| 8 | Gilead Sciences | 194.67 Bn | 168.86 Bn | 6.22 Bn | 1.92 Bn |
| 9 | Pfizer | 171.17 Bn | 117.82 Bn | 10.94 Bn | 3.41 Bn |
| 10 | Quoin Pharmaceuticals | 325,380.52 | -45.14 Mn | - | 1.85 Mn |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1.85 Mn |
| Mar 31, 2026 | 1.70 Mn |
| Dec 31, 2025 | 1.42 Mn |
| Sep 30, 2025 | 1.74 Mn |
| Jun 30, 2025 | 1.74 Mn |
| Mar 31, 2025 | 1.58 Mn |
| Dec 31, 2024 | 1.35 Mn |
| Sep 30, 2024 | 1.45 Mn |
| Jun 30, 2024 | 1.55 Mn |
| Mar 31, 2024 | 1.57 Mn |
| Dec 31, 2023 | 1.39 Mn |
| Sep 30, 2023 | 1.37 Mn |
| Jun 30, 2023 | 1.63 Mn |
| Mar 31, 2023 | 1.68 Mn |
| Dec 31, 2022 | 1.47 Mn |
| Sep 30, 2022 | 1.58 Mn |
| Jun 30, 2022 | 1.94 Mn |
| Mar 31, 2022 | 1.59 Mn |
| Dec 31, 2021 | 1.97 Mn |
| Sep 30, 2021 | 1.04 Mn |
Quoin Pharmaceuticals Selling, General & Administrative API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=selling-general-and-administrative&ticker=QNRX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "selling-general-and-administrative", "ticker": "QNRX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=selling-general-and-administrative&ticker=QNRX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();